Prevention of Bacterial Biofilms on CSF Shunts through the Incorporation of Novel

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$570,115.00
Award Year:
2010
Program:
SBIR
Phase:
Phase I
Contract:
1R43NS071776-01
Award Id:
96486
Agency Tracking Number:
NS071776
Solicitation Year:
n/a
Solicitation Topic Code:
NINDS
Solicitation Number:
n/a
Small Business Information
AGILE SCIENCES, INC., 3309 MILTON RD, RALEIGH, NC, -
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
828576202
Principal Investigator:
STEPHENBRAND
() -
Business Contact:
EVAGARLAND
() -
info@agilesci.com
Research Institute:
n/a
Abstract
DESCRIPTION (provided by applicant): This NIH SBIR project assesses the feasibility of applying a discovery made by the cofounders of Agile Sciences, Inc. to developing a more effective therapeutic strategy toward preventing bacterial infections associated with CSF shunts. Bacterial infections associated with shunts are particularly difficult to treat as bacteria typically form a biofilm on the surface of the shunt. These biofilms act to protect the bacteria from antimicrobial intervention. The cofounders of Agile Sciences, Inc. have discovered a class of novel small molecules that inhibits bacteria9s ability to form biofilms as well as disperses pre-formed bacterial biofilms. The goal of this proposal is to incorporate Agile9s most potent and broadly actin g compound, named Agilyte , into CSF shunt catheters and to assess the antibiofilm and antimicrobial properties of these catheters using in vitro models. To this end, the Specific Aims of this Phase I SBIR Project are: 1. to incorporate Agilyte into silic one catheters. 2. To assess biofilm buildup of Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas aeruginosa on an Agilyte + antibiotic impregnated (AAI) silicone catheter using an in vitro model. 3. To assess the enhanced anti - biofilm an d antimicrobial properties of an Agilyte + antibiotic-impregnated (AAI) silicone catheter toward a clinical sample of bacteria in vitro. PUBLIC HEALTH RELEVANCE: Infections of cerebrospinal fluid (CSF) shunts occur in approximately 10% of all pati ents, and are associated with increased morbidity and mortality. A new strategy for reducing or eliminating these infections would result in substantial increase in quality of life for the hundreds of thousands of people living with hydrocephalus in the Un ited States.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government